Sionna Therapeutics Insider Trades
NASDAQ: SIONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 39 · $134.35M
- Shares bought / sold
- 0 / 5.97M
- Net activity
- Net selling $134.3 million
Sionna Therapeutics insider activity
Over the last 12 months, Sionna Therapeutics insiders reported 49 transactions on SEC Form 4: 0 open-market purchases and 39 sales. Insiders bought $0 and sold $134.3 million worth of stock, for net insider selling of $134.3 million. The largest seller was ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC, with $50.9 million in reported sales.
The most recent filing shows RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M. (Director) selling 3,415,011 shares at $6.32 on Sep 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SION's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SION insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 17, 2026 | Cloonan MichaelPresident & CEO | Award | 109,025 | — | Form 4 |
| Sep 17, 2026 | Cloonan MichaelPresident & CEO | Award | 109,025 | — | Form 4 |
| Sep 17, 2026 | Fitzpatrick JenniferCLO and Head of Program Mgmt. | Award | 28,132 | — | Form 4 |
| Sep 17, 2026 | Fitzpatrick JenniferCLO and Head of Program Mgmt. | Award | 28,133 | — | Form 4 |
| Sep 17, 2026 | McKee CharlotteCMO and Head of R&D | Award | 50,000 | — | Form 4 |
| Sep 17, 2026 | McKee CharlotteCMO and Head of R&D | Award | 50,000 | — | Form 4 |
| Sep 17, 2026 | Ridloff ElenaCFO and CBO | Award | 47,268 | — | Form 4 |
| Sep 17, 2026 | Ridloff ElenaCFO and CBO | Award | 47,269 | — | Form 4 |
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Sale | 33,800 | $252.15K | Form 4 |
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Sale | 3,415,011 | $21.58M | Form 4 |
| Jul 7, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 85,918 | $3.85M | Form 4 |
| Jul 7, 2026 | Thompson Peter A.Director | Sale | 85,918 | $3.85M | Form 4 |
| Jul 6, 2026 | Fitzpatrick JenniferChief Legal Officer | Sale | 10,250 | $446.86K | Form 4 |
| Jul 6, 2026 | Fitzpatrick JenniferChief Legal Officer | Option exercise | 10,250 | $62.63K | Form 4 |
| Jun 30, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 115,844 | $5.27M | Form 4 |
| Jun 30, 2026 | Thompson Peter A.Director | Sale | 115,844 | $5.27M | Form 4 |
| May 27, 2026 | Thompson Peter A.Director | Sale | 101 | $4.49K | Form 4 |
| May 27, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 101 | $4.49K | Form 4 |
| May 11, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 184,639 | $8.53M | Form 4 |
| May 11, 2026 | Thompson Peter A.Director | Sale | 184,639 | $8.53M | Form 4 |
| May 8, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 59,767 | $2.66M | Form 4 |
| May 8, 2026 | Thompson Peter A.Director | Sale | 59,767 | $2.66M | Form 4 |
| May 7, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 48,546 | $2.17M | Form 4 |
| May 7, 2026 | Thompson Peter A.Director | Sale | 48,546 | $2.17M | Form 4 |
| Apr 18, 2026 | Thompson Peter A.Director | Sale | 2,948 | $131.24K | Form 4 |
| Apr 18, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 2,948 | $131.24K | Form 4 |
| Apr 17, 2026 | Thompson Peter A.Director | Sale | 52,397 | $2.34M | Form 4 |
| Apr 17, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 52,397 | $2.34M | Form 4 |
| Apr 16, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 226,906 | $10.29M | Form 4 |
| Apr 16, 2026 | Thompson Peter A.Director | Sale | 226,906 | $10.29M | Form 4 |
| Apr 15, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 235,863 | $10.53M | Form 4 |
| Apr 15, 2026 | Thompson Peter A.Director | Sale | 235,863 | $10.53M | Form 4 |
| Apr 14, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 47,814 | $2.13M | Form 4 |
| Apr 14, 2026 | Thompson Peter A.Director | Sale | 47,814 | $2.13M | Form 4 |
| Mar 5, 2026 | Fitzpatrick JenniferChief Legal Officer | Sale | 10,250 | $347.02K | Form 4 |
| Mar 5, 2026 | Fitzpatrick JenniferChief Legal Officer | Option exercise | 10,250 | $62.63K | Form 4 |
| Feb 3, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 29,063 | $1.30M | Form 4 |
| Feb 3, 2026 | Thompson Peter A.Director | Sale | 29,063 | $1.30M | Form 4 |
| Feb 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 1,890 | $84.24K | Form 4 |
| Feb 2, 2026 | Thompson Peter A.Director | Sale | 1,890 | $84.24K | Form 4 |
| Jan 22, 2026 | TPG GP A, LLC & COULTER JAMES G & WINKELRIED JON10% Owner | Sale | 250,000 | $10.00M | Form 4 |
| Dec 24, 2025 | Thompson Peter A.Director | Sale | 33,356 | $1.49M | Form 4 |
| Dec 24, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 33,356 | $1.49M | Form 4 |
| Dec 19, 2025 | Thompson Peter A.Director | Sale | 875 | $38.93K | Form 4 |
| Dec 19, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 875 | $38.93K | Form 4 |
| Dec 18, 2025 | Thompson Peter A.Director | Sale | 100 | $4.45K | Form 4 |
| Dec 18, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 100 | $4.45K | Form 4 |
| Dec 17, 2025 | Thompson Peter A.Director | Sale | 900 | $40.05K | Form 4 |
| Dec 17, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Sale | 900 | $40.05K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4